Clinical study for laser hair growth system recognized with ASLMS research award

iGrow hair growth system from Apira Science

A clinical study using the iGrow hair growth system from Apira Science (Boca Raton, FL) was recognized at the 33rd Annual Conference of the American Society for Laser Medicine & Surgery (ASLMS; Boston, MA). The study was led by Raymond J. Lanzafame, MD, MBA, FACS, a board-certified surgeon and expert in laser applications and laser research, and was awarded the Best Overall Experimental and Translational Research Award.

Related: Crowdfunding succeeds for at-home laser hair-growth device

The iGrow hair growth system is a hands-free low-level laser therapy (LLLT) hair growth device cleared by the FDA for use at home. Its patented red light technology treats affected areas of the scalp by energizing unhealthy follicle cells and promoting hair growth. It is indicated to promote hair growth in males with androgenetic alopecia who have Norwood Hamilton Classifications of IIa to V.

The clinical study was conducted using a double-blind, randomized controlled trial on 44 men, ages 18–48, with varying levels of androgenetic alopecia (male-pattern baldness) to define the safety and physiologic effects of LLLT, delivered by an iGrow hair growth system, on male scalp hair follicles and surrounding tissue. Participants who submitted to the treatments every other day at home saw a 35 percent increase in hair growth over a 16-week period with no side effects.

Jeff Braile, president of medical products at Apira Science, says that the company has completed a second clinical trial to measure iGrow's effectiveness in treating women’s hair loss.

The study, titled “The Growth of Human Scalp Hair Mediated by Visible Red Light Laser and LED Sources in Males,” has been published in the October 2013 issue of the journal Lasers in Surgery and Medicine; for more information, please visit And for more information on iGrow, please visit


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Nanoparticles, NIR laser light combine to destroy cancer cells

A newly developed method that kills cancer cells using nanoparticles and near-infrared laser light.

Novel post-op patch delivers drug, gene, and light therapy to tumor sites

An adhesive patch can stick to a tumor site, either before or after surgery, to deliver a combination of drug, gene, and light therapy.

Low-level laser therapy is a potential noninvasive treatment for thrombocytopenia

Low-level laser therapy may offer a noninvasive, drug-free treatment for a potentially life-threatening bleeding disorder.

NIR light-activated nanoparticles can precisely target and treat tumors

Novel nanoparticles that use heat and near-infrared light can potentially target and ablate tumors with greater precision.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World